Urgency: Investing in Innovation

News March 15, 2024

The Importance of the National Growth Fund for the Earning Capacity of the Netherlands

The Board of PharmaNL sent a letter to the House of Representatives on March 15, 2024 (specifically to the members of the VVD faction and NSC faction), expressing concern about the considerations surrounding the National Growth Fund.

Brigitte Drees (lead of PharmaNL and CEO Pivot Park): “We must continue to invest in innovation. This is somewhat more long-term than next year’s budget. It requires courage and commitment. Sustainable policy is needed to provide companies and all others involved in NGF applications with the assurance to continue investing in innovation now.”

The full letter can be downloaded here.